Development System
AAVS1_site_13 | SCGE Toolkit
Database of study and experiment data generated by the Somatic Cell Genome Editing Consortium
| A novel human T cell platform to define biological adverse effects of genome editing |
| AAVS1_site_13 |
| Calculated editing efficiency by targeted amplicon deep sequencing |
|
| Editing Efficiency |
| 15000000433 |
|
| SpCas9 |
| P3 Nucleofection Kit |
| Commercial Reagent |
| AAVS1_site_13 |
|
|
| Human |
| CD4/CD8 Human Primary T cell |
|
| Male |
|
| nucleofection |
|
| 75 pmol Cas9 protein; 3-fold molar excess of sgRNA |
|
|
|
|
| ribonucleoprotein (RNP) |
|
|
|
| Measured Values |
| Samples Size: | 3 |
| |
| Mean |
41.18  |
| 1 |
41.698918150234896  |
| 2 |
41.7140358548317  |
| 3 |
40.1194747062502  |
| |
|
| Publication Title |
|
CHANGE-seq reveals genetic and epigenetic effects on CRISPR-Cas9 genome-wide activity. NCBI |